[ Price : $8.95]
FDA approves Amgens Lumakras (sotorasib) for use with its Vectibix (panitumumab) for adult patients with KRAS G12C-mutated metasta...[ Price : $8.95]
CDER posts its latest guidance agenda that shows it is committing to issuing 11 drug quality guidance documents in 2025.[ Price : $8.95]
An FDA update says contrary to an earlier alert, all new neonatal incubators currently supplied in the U.S. do not show concerning...[ Price : $8.95]
FDA grants AstraZeneca traditional approval for Calquence (acalabrutinib) with bendamustine and rituximab for adults with previous...[ Price : $8.95]
CDRHs annual report says it granted marketing authorization to 120 novel devices in 2024, which was four less than the previous ye...[ Price : $8.95]
Federal Register notice: FDA seeks public comments on the use of cannabis-derived products (CDPs) in animals.[ Price : $8.95]
FDA commissioner Robert Califf and three former commissioners offer their perspectives on the ways the incoming administration can...